Abbott Releases New Laser Eye System Developed Using Space Tech

Abbot Medical Optics has recently launched a new device called iDesign Advanced WaveScan Studio System that would allow a more personalized procedure for laser eye surgery patients during laser surgery and laser eye surgery Glasgow cost may even lessen. The iDesign, which was approved by the USFDA in May, also reduces the minimum age required for laser eye procedure by at least three years.

Head of research and development for Abbot Dr. Leonard Borrman says that this new technology marks a greater leap for the US vision correction industry due to a more personalized treatment depending on the uniqueness of the person’s eye.

The iDesign system creates a 3D map of the eye that enables surgeons and eye doctors to see areas of the eye that they could not normally see prior to the introduction of the iDesign device, which was developed using space-age technology being used for NASA’s telescopes.

The system reads the eye at a right five times more than the WaveScan Wavefront, the current system being used, in only about three seconds. The scanning is able to properly identify the eye’s pupil shape and its curvature.

Using this scan, the 3D map is created and is translated into a plan, which is transferred as a blueprint for the laser’s movements during the operation.

The government has previously partnered with Abbot in other projects in the past especially using the latter’s i-STAT system in evaluating concussions of US soldiers.

The study
334 human eyes were used to conduct a study regarding the effectiveness of the iDesign System. The study lasted for two years.

Dr. Maloney, who participated as a surgeon in the study and who has been actively in practice since the first laser eye surgery in 1991, says that the iDesign shows a great improvement and development in the laser eye procedure. He plans on replacing his machine with the iDesign once he receives his version from Abbott.

Among the 334 eyes, almost all but three patients did not feel any difficulty regarding the clarity of their vision amounting to a 99% success rate. Furthermore, 97% of the patients did not feel any difficulty regarding their daily activities post-operation. The study also shows that there was a significant improvement in night driving for patients as well as glare reduction.

One of the patients, Elizabeth Gaffron, said that she believed the new technology made her confident about the success of the procedure and that, with the previous technology, she could not have had a better vision than she does right now.

The iDesign System is only currently allowed to treat nearsightedness and is reported to correct an eye for a 20/20 vision. However, Borrman believes that significant improvements in the system will make it the mainstream for eye surgeons today for other procedures like astigmatism and farsightedness, pending approval of the USFDA of course.